Dimethylarginines, Homocysteine Metabolism, and Cerebrospinal Fluid Markers for Alzheimer's Disease
-
- Sönke Arlt
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
- Edzard Schwedhelm
- Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
- Heike Kölsch
- Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
-
- Holger Jahn
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
- Michael Linnebank
- Department of Neurology, University Zurich, Zurich, Switzerland
-
- Yvo Smulders
- Department of Internal Medicine and Metabolic Unit, VU University Hospital Amsterdam, Amsterdam, The Netherlands
-
- Frank Jessen
- Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
-
- Rainer H. Böger
- Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
-
- Julius Popp
- Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
収録刊行物
-
- Journal of Alzheimer's Disease
-
Journal of Alzheimer's Disease 31 (4), 751-758, 2012-09-11
SAGE Publications